WDB coco CoTSE:7079 -0.75%77 Operating Margin % is 23.19% as of Mar. 2026, which is 12% above its 10-year median of 20.72. GuruFocus rates TSE:7079 with a GF Score™ of 77/100 and a GF Value™ of 円3,452.06 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, WDB coco Co ranks better than 90.57% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. WDB coco Co's Operating Income for the
six
months ended in Mar. 2026 was 円557 Mil. WDB coco Co's Revenue for the
six
months ended in Mar. 2026 was 円2,401 Mil. Therefore, WDB coco Co's Operating Margin % for the quarter that ended in Mar. 2026 was 23.19%.
The historical rank and industry rank for WDB coco Co's Operating Margin % or its related term are showing as below:
TSE:7079'
s Operating Margin % Range Over the Past 10 Years
Min: 18.98 Med: 20.72 Max: 27.7
Current: 19.88
TSE:7079's Operating Margin % is ranked better than 90.57% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 4.845
vs TSE:7079: 19.88
WDB coco Co's 5-Year Average Operating Margin % Growth Rate was -1.00% per year.
WDB coco Co's Operating Income for the
six
months ended in Mar. 2026 was 円557 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was 円957 Mil.
WDB coco Co (TSE:7079) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
WDB coco Co Operating Margin % Related Terms
WDB coco Co Operating Margin % Historical Data
* Premium members only.
The historical data trend for WDB coco Co's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7079 vs VEEV, BTSG, TEM: Operating Margin % Comparison
For the Health Information Services subindustry, WDB coco Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WDB coco Co Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where WDB coco Co's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
WDB coco Co's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WDB coco Co (TSE:7079) has a Operating Margin % of 23.19% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on WDB coco Co and its competitors. This is 12% above median its historical median of 20.72. Over the past decade, WDB coco Co's Operating Margin % has ranged from 18.98 to 27.70. According to the industry distribution chart, WDB coco Co ranks #63 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 9.4%.
Is WDB coco Co's Operating Margin % too high?
WDB coco Co's current Operating Margin % of 23.19% is 12% above median its 10-year median of 20.72. Over the past 10 years, this metric has ranged from a low of 18.98 to a high of 27.70. The Healthcare Providers & Services industry median Operating Margin % is 4.85. WDB coco Co's value of 23.19% is 378.6% above this industry median. Based on the distribution chart, WDB coco Co ranks #63 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, WDB coco Co has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WDB coco Co's Operating Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, WDB coco Co ranks #63 out of 668 companies for Operating Margin %. This places WDB coco Co in the top 9% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 4.85. WDB coco Co's value of 23.19% is 378.6% above this benchmark. Historically, WDB coco Co's own Operating Margin % has ranged from 18.98 to 27.70 over the past decade. While the company's 10-year median is 20.72 vs. the industry median of 4.85, WDB coco Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WDB coco Co's current Operating Margin % of 23.19% is 378.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on WDB coco Co and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WDB coco Co's current Operating Margin % is 23.19%, which is 12% above median its own 10-year median of 20.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WDB coco Co stock overvalued right now?
Based on GuruFocus' analysis, WDB coco Co (TSE:7079) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,452.06, compared to a current price of 円2,528.00 — trading 26.8% below its estimated fair value. The current Operating Margin % is 23.19%, which is 12% above median its 10-year median of 20.72 and 378.6% above the Healthcare Providers & Services industry median of 4.85. WDB coco Co's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For WDB coco Co (TSE:7079), the current Operating Margin % is 23.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WDB coco Co (TSE:7079) Overvalued in 2026?
Based on GuruFocus' analysis, WDB coco Co stock appears to be undervalued.
The current stock price of 円2,528.00 is trading 26.8% below its estimated GF Value™ of 円3,452.06.
GuruFocus considers WDB coco Co to be Modestly Undervalued.
Key valuation signals for TSE:7079:
Operating Margin %: 23.19% (12% above median its 10-year median of 20.72)
GF Value™: 円3,452.06 vs. price of 円2,528.00 (26.8% below fair value)
Industry Position: 378.6% above the Healthcare Providers & Services median (#63 of 668)
No single metric tells the full story. See the TSE:7079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC-related work, PMS facility contract support related work, clinical research support/monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments, such as monitoring, safety information, data management, and statistical analysis. It provides support for the development of generic drugs, such as bioequivalence studies and biosimilars, clinical research, and physician-led clinical trials.
77GF Score
Get the complete analysis for TSE:7079
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7079 has been successfully added to your 
